Menu Search
Equities

Q32 Bio Inc

0T6G:LSE

Q32 Bio Inc

Actions
  • Price (USD)45.60
  • Today's Change-2.79 / -5.77%
  • Shares traded120.00
  • 1 Year change+148.38%
  • Beta--
Data delayed at least 20 minutes, as of Nov 08 2024 18:47 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Q32 Bio Inc's revenues fell -63.97% from 3.21m to 1.16m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 5.01m to a larger loss of 112.96m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-31.38%
Return on equity-85.06%
Return on investment-36.35%
More ▼

Cash flow in USDView more

In 2023, Q32 Bio Inc increased its cash reserves by 15.54%, or 5.28m. Cash Flow from Investing totalled 101.33m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 96.23m for operations while cash generated from financing totalled 184.00k.
Cash flow per share-8.81
Price/Cash flow per share--
Book value per share2.79
Tangible book value per share2.79
More ▼

Balance sheet in USDView more

Q32 Bio Inc appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio6.49
Quick ratio--
Total debt/total equity0.3746
Total debt/total capital0.2725
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.